IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)
90.67
-1.32 (-1.43%)
Jul 9, 2025, 3:30 PM IST
NSE:IOLCP Revenue
In the fiscal year ending March 31, 2025, IOL Chemicals and Pharmaceuticals had annual revenue of 20.79B INR, down -2.51%. IOL Chemicals and Pharmaceuticals had revenue of 5.28B in the quarter ending March 31, 2025, with 4.73% growth.
Revenue
20.79B
Revenue Growth
-2.51%
P/S Ratio
1.30
Revenue / Employee
7.49M
Employees
2,777
Market Cap
27.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 20.79B | -535.80M | -2.51% |
Mar 31, 2024 | 21.33B | -843.20M | -3.80% |
Mar 31, 2023 | 22.17B | 330.90M | 1.52% |
Mar 31, 2022 | 21.84B | 2.17B | 11.03% |
Mar 31, 2021 | 19.67B | 725.10M | 3.83% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.83B |
IOL Chemicals and Pharmaceuticals News
- 2 months ago - IOL Chemicals and Pharmaceuticals shares jump nearly 5% after China approves Ibuprofen export - Business Upturn
- 2 months ago - Why are IOL Chemicals share price falling 3% today? Check here - Business Upturn
- 4 months ago - IOL Chemicals shares surge 4% after EDQM certification for Quetiapine Fumarate - Business Upturn
- 6 months ago - IOL Chemicals and Pharmaceuticals shares rise nearly 4% as board approves 1:5 stock split - Business Upturn
- 7 months ago - IOL Chemicals shares surge 7% after company plans to consider stock split - Business Upturn
- 8 months ago - IOL Chemicals & Pharmaceuticals shares fall nearly 5% after disappointing Q2 FY25 results - Business Upturn